<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01230268</url>
  </required_header>
  <id_info>
    <org_study_id>CPT2010-05</org_study_id>
    <nct_id>NCT01230268</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Pharmacokinetics of C3G and to Estimate Antioxidative Markers After Repeated Administration of Mulberry Fruit Extract</brief_title>
  <acronym>C3G</acronym>
  <official_title>A Study to Evaluate Pharmacokinetics of C3G and to Estimate Antioxidative Markers After Repeated Administration of Mulberry Fruit Extract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rural Development Administration, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate pharmacokinetic-pharmacodynamic property of C3G after
      administration of Mulberry fruit extract to 12 healthy Korean volunteers. Plasma
      concentration of C3G and the antioxidative markers such as total antioxidative capacity and
      attack of free oxygen radical will be measured.

      Additional objective is to investigate the multiple dose (2 weeks) safety of daily 1000mg
      Mulberry fruit extract.

      This study, as an exploratory trial, does not required statistical hypothesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax - Maximum Observed Concentration - C3G in Plasma</measure>
    <time_frame>Blood samples collected over 6 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC0-inf - Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated) - C3G in Plasma</measure>
    <time_frame>Blood samples collected over 6 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Antioxidative markers</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>for 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Mulberry fruit extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily 1000 mg oral Mulberry fruit extract is given to each subject for 2 weeks from Day2 after measuring antioxidative marker without intervention on Day1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mulberry fruit extract</intervention_name>
    <description>1000 mg oral daily dose for 2 weeks</description>
    <arm_group_label>Mulberry fruit extract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body weight &gt;55 kg for male, &gt;45 kg for female (within 80-120% of Ideal body weight)

          -  Give written informed consent and voluntarily decide participation

        Exclusion Criteria:

          -  Acute or chronic disease symptom on screening

          -  Existing active and clinically significant disease involving more than one organ
             system

          -  Known allergy to Mulberry or other berries

          -  Positive drug or alcohol screening

          -  Smokers of 10 or more cigarettes per day

          -  Participation in a clinical trial during last 2 month prior to the start of the study

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Seok Yim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2010</study_first_submitted>
  <study_first_submitted_qc>October 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2010</study_first_posted>
  <last_update_submitted>December 13, 2010</last_update_submitted>
  <last_update_submitted_qc>December 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dong-Seok Yim</name_title>
    <organization>Seoul St. Mary's Hospital</organization>
  </responsible_party>
  <keyword>C3G</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Antioxidant</keyword>
  <keyword>Mulberry</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

